1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Country Review 2016: India

IMS Country Review 2016: India

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: India
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 5
PRICING SYSTEM 5
REGULATORY ENVIRONMENT 5
INDUSTRY ENVIRONMENT 5
CHANNELS OF DISTRIBUTION 9
INDIA DATA COLLECTION 10
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 11
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 11
FIGURE 2: AUDITED MARKET TREND 12
FIGURE 3: LEADING 35 LOCAL COMPANIES 13
FIGURE 4: LEADING 35 CORPORATIONS 15
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 17
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 18
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 19
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 20
FIGURE 8: A2B ANTIULCERANTS 20
FIGURE 9: A7G ORAL ELECTROL. REPLACER 21
FIGURE 10: A10C HUMAN INSULIN+ANALOGUES 22
FIGURE 11: A10J BIGUANIDE ANTIDIABETICS 23
FIGURE 12: B3A HAEMATINICS.IRON and COMBS 24
FIGURE 13: C9D ANGIOTEN-II ANTAG, COMB 25
FIGURE 14: D7B TOP.CORTICOSTEROIDS COMB 26
FIGURE 15: J1C BROAD SPECTR.PENICILLINS 27
FIGURE 16: J1D CEPHALOSPORINS and COMBS 28
FIGURE 17: J5B ANTIVIRALS EXCL ANTI-HIV 29
FIGURE 18: L1G MAB ANTINEOPLASTICS 30
FIGURE 19: L3A IMMUNOSTIM AG EX INTFRON 31
FIGURE 20: M1A ANTIRHEUMATIC N-STEROID 32
FIGURE 21: N3A ANTI-EPILEPTICS 33
FIGURE 22: T2D DIABETES TESTS 34
FIGURE 23: LEADING 40 PRODUCTS 35
FIGURE 24: LEADING 40 NEW PRODUCTS 37
FIGURE 25: LEADING 15 PRODUCT FORMS 40
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 41
SECTION 3: APPENDICES 43
APPENDIX 1: AUDITED UNIVERSE 43
APPENDIX 2: COUNTRY SPECIFIC ALERTS 44
APPENDIX 3: MEASURE INDEX 47
APPENDIX 4: SALES DATA MEASURES 49
APPENDIX 5: *LATEST FACTORS 51
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 55
APPENDIX 7: CORPORATIONS 57
APPENDIX 8: PRODUCT NAMES 58
APPENDIX 9: THERAPIES 60
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 61

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.